This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Containment Remove Genetic Engineering Remove Pharma Companies Related Topics
Immune Response In-Vivo Insulin Genetics Protein DNA Vaccine Vaccination FDA Approval Life Science More Related Topics >
article thumbnail

COVID prompts another milestone, as India clears first DNA vaccine

pharmaphorum

AUGUST 23, 2021

The vaccine may be a latecomer to the COVID-19 vaccine arsenal, but its approval signals the potential of DNA vaccines and is a boost to companies working in this space. The company also says that it can update the vaccine very easily to deal with mutations in the virus.

DNA 98
DNA Vaccination Vaccine Genetic Engineering 98
article thumbnail

Company Spotlight: Cue Biopharma Innovates in the Immunotherapy Space with its Immuno-STAT Platform

XTalks

AUGUST 17, 2020

A growing area in the immunotherapy space is the development of biological modulators, which are genetically engineered proteins that target specific components of the immune system. Image from Cue Biopharma. The Immuno-STAT Molecules. The T cell epitope is usually an 8 – 10 amino acid peptide.

Protein 98
Protein Engineer Immune Response In-Vivo 98
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024